Article
Identification of Bile Acid-Derived Chemical Chaperone(s) Targeting E46K-Mutated Alpha-Synuclein Protein to Treat Parkinson's Disease: Molecular Modelling, Docking, ADME, and Simulation Studies.
Applied biochemistry and biotechnology - 1 Apr 2024
Kaur Navpreet, Singh Rimaljot, Das Agneesh P, Agarwal Subhash M, Dhingra Neelima, Kaur Tanzeer
Abstract excerpt
Aggregated α-synuclein (α-syn) present inside small cytoplasmic inclusions in the substantia nigra region marks the major pathological hallmark of Parkinson's disease (PD) and makes it an attractive target for the drug development process. Certain small-molecule chaperones (such as DCA, UDCA, TUDCA) presented the ability to prevent misfolding and aggregation of α-syn as well as to disentangle mature α-syn amyloid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.